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Abstract
IL-27 is an important and non-redundant regulator of effector T cell accumulation in non-lymphoid tissues during infection.
Using malaria as a model systemic pro-inflammatory infection, we demonstrate that the aberrant accumulation of CD4+ T
cells in the liver of infected IL27R2/2 (WSX-12/2) mice is a result of differences in cellular recruitment, rather than changes in
T cell proliferation or cell death. We show that IL-27 both inhibits the migratory capacity of infection-derived CD4+ T cells
towards infection-derived liver cells, but also suppresses the production of soluble liver-derived mediator(s) that direct CD4+
T cell movement towards the inflamed tissue. Although CCL4 and CCL5 expression was higher in livers of infected WSX-12/2
mice than infected WT mice, and hepatic CD4+ T cells from WSX-12/2 mice expressed higher levels of CCR5 than cells from
WT mice, migration of CD4+ T cells to the liver of WSX-12/2 mice during infection was not controlled by chemokine (R)
signalling. However, anti-IL-12p40 treatment reduced migration of CD4+ T cells towards infection-derived liver cells,
primarily by abrogating the hepatotropic migratory capacity of T cells, rather than diminishing soluble tissue-derived
migratory signals. These results indicate that IL-27R signalling restricts CD4+ T cell accumulation within the liver during
infection primarily by suppressing T cell chemotaxis, which may be linked to its capacity to repress Th1 differentiation, as
well as by inhibiting the production of soluble, tissue-derived chemotaxins.
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Introduction
The IL-12 cytokine superfamily member IL-27 is an important
regulator of pro-inflammatory immune responses [1,2]. Increased
numbers of effector CD4+ T cells are found in the livers of IL-27R
(TCCR/WSX-1) deficient mice during Plasmodium berghei NK65,
Toxoplasma gondii, Leishmania donovani and Trypanasoma cruzi infec-
tions [3–6], in the lungs of WSX-12/2 mice during Mycobacterium
tuberculosis infection and in the intestine of WSX-12/2 mice during
Trichuris muris infection [7–9]. The mechanisms through which IL-
27 limits Th1, Th2 and Th17 responses, enhances CD4+ T cell IL-
10 production and regulates the polarisation of Foxp3+ regulatory
T cells, have been widely studied [1,2]. By contrast, the pathways
by which IL-27 inhibits effector T cell accumulation in non-
lymphoid tissues during infection are poorly understood, but may
include limiting CD4+ T cell proliferation or enhancing cellular
apoptosis in situ.
In support of these theories, CD4+ T cells from WSX-12/2
mice are hyper proliferative following in vitro stimulation with anti-
CD3/CD28 [6,10] and proliferate more extensively in the lungs of
WSX-12/2 mice than WT mice during Mycobacterium tuberculosis
infection [9]. Whilst the role of IL-27 in controlling T cell
apoptosis has not been directly examined, IL-6 and IL-12 are both
known to exert anti-apoptotic effects on CD4+ T cells [11,12] and
concentrations of both these cytokines are significantly increased
in WSX-12/2 mice during infection [9,10,13,14]. Alternatively,
IL-27 might limit the autonomous chemotactic activity of CD4+ T
cells, and/or affect the expression of liver derived chemotactic/
migratory factors. In support of this latter hypothesis, we have
shown that splenic CD4+ T cells from malaria-infected WSX-12/
2 mice express higher levels of CCR5 than cells from WT mice
and are consequently hyper responsive to CCR1 and CCR5
ligands [15].
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In this study we have used Plasmodium berghei NK65 as a model
systemic infection, to investigate the pathways by which IL-27
restricts effector CD4+ T cell accumulation in the liver during
inflammation. We demonstrate that intrahepatic CD4+ T cell
proliferation and apoptosis are unaffected by the absence of WSX-
1 signalling. Instead our results show that IL-27 attenuates CD4+
T cell accumulation in the liver by inhibiting T cell migratory
pathways. Surprisingly, we find that CD4+ T cell accumulation in
the livers of infected WSX-12/2 mice is not orchestrated by non-
classical chemokine pathways. Rather, increased CD4+ T cell
migration in infected WSX-12/2 mice seems to result from the
loss of IL-27-mediated suppression of Th1 differentiation and
chemotaxis. We conclude that IL-27 restricts the accumulation of
pathogenic T cells in the liver during infection by co-ordinately
suppressing soluble, non-chemokine, chemotactic signals and by
repressing the development of highly migratory Th1 cells. These
results expand our understanding of how IL-27 signalling regulates
tissue inflammation and opens up new avenues of research into
how T cells enter inflamed tissues.
Materials and Methods
1. Ethics Statement
All animal work was approved following local ethical review by
LSHTM and University of Manchester Animal Procedures and
Ethics Committees and was performed in strict accordance with
the U. K Home Office Animals (Scientific Procedures) Act 1986
(approved H.O Project Licenses 70/6995 and 70/7293).
2. Mice and Parasites
C57BL/6 mice were purchased from Harlan, UK. Breeding
pairs of C57BL/6 IL-27R deficient (WSX-12/2) mice [10] were
provided by Amgen Inc (Thousand Oaks, USA). Animals were
maintained under barrier conditions in individually ventilated
cages. Cryopreserved P. berghei NK65 parasites were passaged once
through C57BL/6 mice before being used to infect experimental
animals.
6–10 week old mice were infected by intravenous injection of
104 parasitized red blood cells (pRBC). The course of infection was
followed by monitoring weight loss and peripheral parasitaemia
every 2nd day. Parasitaemia was assessed by examination of
Giemsa-stained thin-blood smears.
In some experiments, 250 mg anti-IL-12p40 (C17.8, BioXCell
Inc, West Lebanon, USA) was injected i.p. every other day or
250 mg anti-CCL5 (R6G9, provided by Professor T Lane,
University of California) or 250 mg TAK779 (obtained through
the NIH AIDS Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH) were injected i.p. daily starting
on day 7 post-infection.
3. Flow Cytometry
Single cell suspensions of spleen and livers were prepared by
homogenising through a 70 mm cell strainer (BD Biosciences). Red
blood cells (RBCs) were lysed using RBC lysis buffer (BD
Biosciences). Leukocytes were enriched from liver homogenates
by resuspending cell pellets in a 32% Percoll 3% 106 PBS 65%
HBSS solution and centrifuging at 930 g for 10 minutes. Floating
hepatocytes were removed and the cell pellet was collected.
Absolute live cell numbers were calculated by microscopy and
trypan blue exclusion.
Phenotypic characterisation of cell populations was performed
according to previously published protocols [14,15]. Cells were
surface stained with: anti-mouse CD4 (clone GK1.5), CD44 (IM7),
CD62L (MEL-14), CCR1 (PA1-41062), CCR4 (2G12), CCR5
(7A4), CCR7 (4B12), CXCR3 (CXCR3-173), CXCR4 (2B11),
CXCR6 (221002), and KLRG1 (2F1) followed by intracellular
staining of T-bet (4B10), Gata3 (TWAJ), foxp3 (FJK-16s), Ki67
(SolA15) and chemokine receptors. All antibodies were purchased
from eBioscience or BD Biosciences.
For the analysis of cell proliferation in vivo, 1.25 mg sterile BrdU
(5-bromodeoxyuridine) was injected ip. one hour before sacrifice.
Intracellular BrdU incorporation was measured using an anti-
BrdU antibody (clone PRB-1, eBioscience). T cell apoptosis was
assessed using Annexin V (BD biosciences).
All flow cytometry acquisition was performed using an LSR II
(BD Systems, UK). All analysis was performed using Flowjo
Software (Treestar Inc, OR, USA). Fluorescence minus one
controls were used to validate flow cytometric data.
4. Real Time PCR
RNA was extracted from livers (RNeasy, Qiagen) and DNAse I
treated (Ambion, Texas, USA) before cDNA synthesis. mRNA
levels of chemokine genes were quantified in whole liver tissue by
real time PCR (Taqman) using validated gene expression assays
from ABI Biosystems (Warrington, UK). cDNA expression for
each sample was standardised to the housekeeping gene beta-actin.
Data are presented as fold change (log10) in gene expression in
infected tissues relative to uninfected tissues. Cycling conditions
were: initialisation 2 min at 50uC and 10 min at 95uC followed by
40 cycles of 15 sec at 95uC and 1 min at 60uC.
5. Transwell Migration Assays
Migration of purified CD4+ T cells was assessed by their
movement through a 5 mm pore transwell plate (Costar). 56106
cells from whole liver single cell suspensions were plated in the
outer well of the transwell, and incubated at 37uC and 5% CO2
for one hour. Splenic CD4+ T cells were purified by magnetic
bead separation (Miltenyi Biotec), labelled with 5 mM CFSE for
3 minutes (Molecular Probes, Invitrogen), washed twice with
HBSS and then 16106 CD4+ T cells were plated in each inside
well; cells were then incubated at 37uC and 5% CO2 for a
further three hours. For analysis of cell migration towards the
liver cells, cells in the outer well were collected and run on the
flow cytometer to enumerate CFSE+ cells. For analysis of CD4+
T cell migration towards recombinant CCL4, CCL5 or
CXCL12 (R&D Systems, Abingdon, UK or Peprotech, London,
UK) all at 100 ng/ml), the number of cells that had migrated
into the outer well was counted by light microscopy. The
optimal concentrations of chemokines were determined in dose-
response assays (results not shown).
In some migration assays chemokine inhibitors were used. In
these experiments, purified CD4+ T cells were isolated and
incubated with 100 ng/ml pertussis toxin (Sigma), 10 mg/ml anti-
CCL5 or 1 mg/ml TAK779 or AMD3100 for two hours. Cells
were then washed and treated as above. In cases where anti-CCL5
was used, liver cell suspensions were also incubated with 10 mg/ml
anti-CCL5 during the one hour pre-assay incubation.
6. Adoptive Transfer Experiments
On day 10 post-infection mice were sacrificed and splenic CD4+
T cells isolated as described above. Cells were labelled with CFSE
and incubated with either 100 ng/ml pertussis toxin or PBS for
two hours at 37uC. Cells were then counted and 76106 of either
the untreated or treated cells were injected i–v into recipient,
infected (day 10 PI) mice. Mice were sacrificed on day 13 PI and
CFSE+ cells in the liver were enumerated by flow cytometry.
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7. Histology and Immunofluorescence
Livers were removed from uninfected and malaria-infected
(D14 PI) mice and fixed in 10% formalin saline. Fixed tissues were
paraffin embedded and sectioned before being stained with H&E.
For immunofluoresence, sections were deparaffinization and
dehydrated prior to antigen retrieval. Samples were incubated
overnight with anti-CD45 (IBL-3/16) and anti-CD3 (145-2C11)
primary antibodies (BD and AbD Serotec), washed, and incubated
for an hour with Alexa flour 488 donkey anti rat and Alexa flour
488 goat anti hamster secondary antibodies (Life Technologies).
Slides were examined under 620 magnification using a Leica
DMLB microsystem with CoolSnap camera and software.
8. Statistics
Statistical significance was determined using a Student’s T-test
or one-way ANOVA with Tukey’s post hoc analysis. Results were
classified as significantly different when P,0.05. All data are
representative of 3 independent experiments.
Results
1. Enhanced Accumulation of CD4+ T Cells in the Liver of
Malaria-infected WSX-12/2 Mice is not a Result of Altered
in situ Proliferation or Apoptosis
To define the kinetics of altered intrahepatic accumulation of
CD4+ T cells in WSX-12/2 mice during malaria infection, we
compared the frequencies and total numbers of intrahepatic CD4+
T cells in WT and WSX-12/2 mice on various days of infection.
No differences in either the frequencies or numbers of CD4+ T
cells were observed in the livers of WT and WSX-12/2 mice on
days 4, 7 or 10 post-infection (PI) (Fig. 1A–C). By contrast,
significantly increased frequencies and numbers of intrahepatic
CD4+ T cells were observed in WSX-12/2 mice on day 14 PI, at
the time when they succumbed to infection (Fig. 1A–C and results
not shown). As previously shown [3], WSX-12/2, but not WT
mice, developed severe liver necrosis and pathology on day 14 of
infection, which was associated with accumulation of CD3+
lymphocytes within the tissue parenchyma proximal to central
vein and sinusoids (Figure S1).
Ablation of WSX-1 signalling did not significantly affect the
level of intrahepatic CD4+ T cell proliferation or apoptosis;
intrahepatic CD4+ T cell expression of Ki67 and BrdU uptake was
similar in WSX-12/2 and WT mice and there were no differences
in expression of Annexin V or 7-AAD on either day 7 or day 14 of
infection (Fig. 1D–G). Combined, these data indicate that
increased accumulation of CD4+ T cells in livers of WSX-12/2
mice during malaria infection is not a result of dysregulated CD4+
T cell proliferation or apoptosis within the inflamed tissue.
2. Enhanced Migration of CD4+ T Cells from Malaria-
infected WSX-12/2 Mice towards the Inflamed Liver
We next hypothesised that increased CD4+ T cell accumulation
within livers of WSX-12/2 mice after day 10 of infection was due
to active CD4+ T cell migration, most probably from the spleen,
which is the major site of T cell priming during malaria infection
[16]. Using an in vitro migration assay, we observed that very few
CD4+ T cells from uninfected or day 7 infected WT or WSX-12/
2 mice or day 14 infected WT mice migrated across the transwell
towards either naı¨ve or infection-derived (D14) liver cells (Fig. 1H
and results not shown). By contrast, CD4+ T cells from day 14-
infected WSX-12/2 mice exhibited significant migration towards
day 14-derived liver cells (Figure 1H). Thus, CD4+ T cells acquire
significant hepatotropic migratory capacity specifically in WSX-
12/2 mice only during the later stages of P. berghei NK65 infection.
Significantly more CD4+ T cells from infected (D14 PI) WSX-12/
2 mice migrated towards liver cells from infected (D14 PI) WSX-
12/2 mice than migrated towards liver cells from infected (D14 PI)
WT mice, indicating that factors produced by the infected liver
also regulate CD4+ T cell migration, and that these signals differ
between WT and WSX-12/2 mice (Fig. 1H).
Migration of CD4+ T cells from infected (D14 PI) WT and
WSX-12/2 mice cells towards naı¨ve liver cells and media was
uniformly low (results not shown and Figure 1I), indicating that
active, infection-induced, tissue signals were required to drive
significant levels of CD4+ T cell migration. Thus, these data
indicate that IL-27 represses the migratory capacity of splenic
CD4+ T cells toward the inflamed liver during malaria infection
and that both T cell-intrinsic and extrinsic factors appear to
control CD4+ T cell chemotaxis.
3. Chemokine-chemokine Receptor Pathways are
Dysregulated in WSX-12/2 Mice during Malaria Infection
To identify the soluble, WSX-1-regulated liver-derived signal(s)
that control CD4+ T cell migration, we first compared the
repertoire and levels of chemokine production in livers from WT
and WSX-12/2 mice on day 7 and day 14 of infection. Elevated
levels of CCL3, CCL4, CCL5 and CXCL9 mRNA were detected
in the livers of both WT and WSX-12/2 mice on day 7 of
infection, whereas CCL3, CCL4, CCL5 and CCL20 mRNA levels
were increased on day 14 of infection. CCL4 was expressed at
significantly higher levels in livers of WSX-12/2 mice compared
to WT mice on day 7 of infection (Fig. 2A), whereas CCL4 and
CCL5, both ligands for CCR5, were expressed at 5–10-fold higher
levels in livers of WSX-12/2 mice compared to WT mice on day
14 of infection (Fig. 2B). IL-27R signalling therefore significantly
and specifically represses production of CCL4 and CCL5 in the
inflamed liver during malaria infection.
We next determined whether hepatotropic CD4+ T cells in
infected WSX-12/2 mice expressed a repertoire of chemokine
receptors that enabled them to respond to the elevated CCL4 and
CCL5 signals. Chemokine receptor expression among intrahepatic
CD4+ T cells – with the exception of CCR5 - did not differ
significantly between naı¨ve and infected (D14 PI) mice (Fig. 2C–
E). Interestingly, the proportion of intrahepatic CD4+ T cells
expressing CCR5 was significantly higher in WSX-12/2 mice
than in WT mice on day 14 PI, whereas CXCR3 expression was
higher among CD4+ T cells from WT mice (Fig. 2C–E). The
majority of intrahepatic CD4+CCR5+ cells in infected WT and
WSX-12/2 mice co-expressed CXCR3, around 50% co-ex-
pressed CXCR6 and few cells co-expressed CCR1 (results not
shown). In terms of absolute cell numbers, very few CD4+ T cells
were found in the livers of naı¨ve mice (Fig. 2F). In contrast,
significantly higher numbers of CCR1+, CCR5+, CXCR3+,
CXCR4+ and CXCR6+ T cells were found in the livers of
WSX-12/2 mice on day 14 of infection than in infected WT mice
(Fig. 2G), due primarily to the significant increase in total CD4+ T
cells accumulating in the livers of WSX-12/2 mice during
infection (Fig. 1A–C).
4. Altered Migration of CD4+ T Cells to the Liver in WSX-
12/2 Mice during Infection is not a Result of
Dysregulated Chemokine Receptor Signalling
The above data clearly demonstrate that IL-27 regulates the
CCL4/CCL5-CCR5 axis within the liver during malaria infec-
tion. We postulated therefore that blocking CCL4/CCL5-CCR5
signalling should reduce migration to, and accumulation of, CD4+
WSX-1 Limits Intrahepatic CD4+ T Cell Responses
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T cells in the livers of WSX-12/2 mice during infection.
Surprisingly, although treatment with TAK779 (a CXCR3 and
CCR5 antagonist), anti-CCL5 mAb, AMD3100 (inhibits
CXCL12) and Pertussis toxin (PTX; inhibitor of all Gi protein
coupled chemokine receptors) all significantly suppressed the
chemotaxis of infection-derived, WSX-12/2, CD4+ T cells
towards the respective recombinant chemokines (Fig. 3A, B),
none of these inhibitors prevented the migration of the purified
CD4+ T cells towards infection-derived, WSX-12/2 or WT, liver
cells (Fig. 3C and results not shown for WT liver cells).
Consistent with the in vitro data, blockade of CXCR3/CCR5 by
TAK779 and neutralisation of CCL5 both failed to suppress CD4+
T cell accumulation in WSX-12/2 livers (Fig. 3D, E). CD4+ T
cells removed from anti-CCL5- and TAK779-treated mice also
exhibited unimpaired migration to infection-derived liver cells
when placed in a transwell assay in vitro (Fig. 3F). In addition, and
in agreement with the above data, PTX-treated CD4+ T cells were
able to migrate normally to the livers of infected mice in vivo
(Fig. 3G). These data show that although chemokine pathways are
dysregulated in WSX-12/2 mice during malaria infection,
classical chemokine receptor pathways do not control CD4+ T
cell accumulation within the liver.
5. Anti-IL-12p40 mAb Treatment Attenuates Th1
Polarisation and Suppresses Intrahepatic CD4+ T Cell
Accumulation in WSX-12/2 Mice during Malaria Infection
The vast majority of CD4+ T cells in the livers of both naı¨ve and
infected, WT and WSX-12/2 mice, were Th1 cells expressing
both CD44 and T-bet (Fig. 4A, B). Consequently, significantly
Figure 1. Accumulation of CD4+ T cells in the liver of WSX-12/2 mice during malaria infection is caused by increased migration. (A)
Representative Histograms, (B) frequencies and (C) numbers of intrahepatic CD4+ T cells in the liver of WT and WSX-12/2 mice during infection. (D–G)
The mean frequencies of intrahepatic CD4+ T cells expressing (D) BrDU, (E) Ki67 (F) annexin V+/7-AAD2 and (G) annexin V+/7-AAD+. (H–I) The
migration of splenic CD4+ T cells from naı¨ve, D7 and D14 infected mice towards liver homogenate cells from (H) infected (D14) or (I) naı¨ve mice. Data
are the mean +/2 SEM of the group with 3–5 mice per group. Data are representative of 3 independent experiments. *P,0.05, **P,0.01 WT vs. WSX-
12/2 mice.
doi:10.1371/journal.pone.0078486.g001
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Figure 2. WSX-1 signalling restricts chemokine pathways in the liver during malaria-infection. (A, B ) Chemokine gene expression in the
livers of WT and WSX-12/2 mice on (A) day 7 and (B) day 14 of infection. (C) Representative dot plots of chemokine receptor expression by
WSX-1 Limits Intrahepatic CD4+ T Cell Responses
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higher absolute numbers of CD44+ and T-bet+ CD4+ T cells
accumulated within the livers of infected (but not naı¨ve) WSX-12/
2 mice compared with WT mice (Fig. 4C, D). Thus, these data
indicate that increased CD4+ T cell accumulation in the livers of
WSX-12/2 mice during infection is almost entirely driven by
increased migration and/or retention of Th1 cells. As anti-IL-
12p40 mAbs inhibit T-bet expression and Th1 cell differentiation
in the spleen of malaria-infected WSX-12/2 mice [14], where the
hepatotropic cells likely originate (16), we hypothesised that
suppressing Th1 responses in WSX-12/2 mice by administering
anti-IL-12p40 mAbs would significantly attenuate CD4+ T cell
accumulation in the livers of WSX-12/2 mice during malaria
infection. As expected, anti-IL-12p40 mAb treatment of WSX-12/
2 mice from day 7 of infection onwards significantly reduced both
the proportion and the absolute number of T-bet expressing CD4+
T cells accumulating in the liver (Fig. 4E, F).
CD4+ T cells from anti-IL-12p40 mAb-treated WSX-12/2
mice showed reduced migration towards liver cells from (untreat-
ed) infected WSX-12/2 mice compared with CD4+ T cells from
infected but untreated WSX-12/2 mice, indicating that anti-IL-
12-mAb treatment significantly reduced CD4+ T cell migratory
capacity (Fig. 4G). In addition, CD4+ T cells from both IL-12p40-
mAb treated and untreated infected WSX-12/2 mice showed
slightly reduced (not-significant) migration towards liver cells from
intahepatic CD4+ T cells from uninfected and infected mice (D14 PI). (D–G) The (D, E) Frequencies and (F, G) numbers of CCR expressing intra-hepatic
CD4+ T cells from (D, F) uninfected and (E, G) infected (14 PI) WT and WSX-12/2 mice. Data are the mean +/2 SEM of the group with 3–5 mice per
group. Data are representative of 3 independent experiments. *P,0.05, **P,0.01 WT vs. WSX-12/2 mice.
doi:10.1371/journal.pone.0078486.g002
Figure 3. Abrogation of chemokine receptor signalling does not limit CD4+ T cell accumulation in the livers of WSX-12/2 mice
during malaria infection. The effect of inhibitors of chemokine receptor signalling on the migration of CD4+ T cells from infected (D14 PI) WSX-12/
2 mice towards (A) CCL4, CCL5, (B) CXCL12 and (C) liver homogenate cells from infected (D14 pi) WSX-12/2 mice. (D) Representative histogram and
(E) numbers of CD4+ T cells accumulating in the livers of treated and untreated WSX-12/2 mice (D14 pi). (F) The migration of CD4+ T cells from treated
infected (D14 PI) WSX-12/2 mice towards liver homogenate cells from infected (D14 PI) WSX-12/2 mice. (G) The numbers of pertussis toxin or control
treated CD4+ T cells accumulating in the liver on day 13 pi. Data are the mean +/2 SEM of the group with 3–5 mice per group. Data are
representative of 3 independent experiments. *P,0.05 between highlighted groups.
doi:10.1371/journal.pone.0078486.g003
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Figure 4. Neutralisation of IL-12 signalling reduces accumulation of pathogenic Th1 cells in the livers of WSX-12/2 mice. The (A, B)
frequencies and (C, D) numbers of intrahepatic CD4+ T cells from (A,C) uninfected and (B,D) infected (day 14 PI) WT and WSX-12/2 mice expressing
WSX-1 Limits Intrahepatic CD4+ T Cell Responses
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anti-IL-12-mAb treated mice. (Fig. 4G). Thus, IL-12 appears to
play a major role in promoting CD4+ T cell migration to the liver
of WSX-12/2 mice during malaria infection, primarily by
directing Th1 cell differentiation, rather than eliciting the
production of soluble chemotactic signals from the inflamed liver.
Discussion
In this study we have demonstrated that IL-27R/WSX-1
signalling is required to prevent the accumulation of large
numbers of CD4+ T cells in non-lymphoid organs during the
later stages of malaria infection. In so doing, IL-27 prevents the
onset of potentially fatal liver pathology [3]. Surprisingly, we found
that, compared with WT mice, there were no differences in the
extent of in situ CD4+ T cell proliferation or apoptosis in the livers
of WSX-12/2 mice during infection. Rather, the aberrant
accumulation of CD4+ T cells in the livers of malaria-infected
WSX-12/2 mice appears to be entirely driven by increased T cell
migration: Splenic CD4+ T cells from malaria-infected WSX-12/
2 mice migrated towards liver homogenate cells, from either
infected WT or WSX-12/2 mice, significantly more efficiently
than CD4+ T cells from infected WT mice. In addition, CD4+ T
cells from infected WSX-12/2 mice migrated towards liver
homogenate cells from infected WSX-12/2 mice significantly
more efficiently than they did towards liver homogenate cells from
infected WT mice. Thus, our results suggest that IL-27 simulta-
neously restricts the chemotactic capacity of CD4+ T cells, and
also limits the production of soluble, liver-derived signals that
direct T cell migration towards the inflamed tissue.
Intrahepatic CD4+ T cells from infected WSX-12/2 mice
expressed higher levels of CCR5 than corresponding cells from
infected WT mice and, compared with infected WT mice, CCL4
and CCL5 were expressed at higher levels in the livers of infected
WSX-12/2 mice. As CCR1 and CCR5 play important roles in
promoting lymphocyte recruitment to the liver during a variety of
different inflammatory conditions [17], and as splenic CD4+ T
cells from infected WSX-12/2 mice are hyper-responsive to
CCL4 and CCL5 [15], we initially expected that the enhanced
migration to, and accumulation of, CD4+ T cells in the inflamed
livers of infected WSX-12/2 mice was driven by up-regulation of
the CCR5-CCL4/CCL5 pathway. Surprisingly, however, block-
ade of chemokine receptor signalling using TAK779, AMD3100,
anti-CCL5 mAb and pertussis toxin (blocking all Gi coupled
receptors) did not prevent chemotaxis of CD4+ T cells from
infected WSX-12/2 mice towards infection-derived liver homog-
enate cells in vitro, suggesting that IL-27(R) inhibits CD4+ T cell
migration to the liver via classical chemokine(R)-independent
mechanisms. It is unlikely that there are technical explanations for
these results as the treatments prevented the chemotaxis of
infection-derived CD4+ T cells towards the relative recombinant
chemokines, and pertussis toxin treatment inhibited chemotaxis
towards all tested chemokines. Furthermore, chemokine pathway
blockade failed to reduce accumulation of CD4+ T cells in the
livers of infected WSX-12/2 mice in vivo. Consequently, our
results identify a novel IL-27(R) dependent pathway that limits
CD4+ T cell migration to and accumulation within the liver during
infection and inflammation.
Whilst we have been unable to identify the IL-27(R)-regulated
tissue-derived soluble signals that promotes CD4+ T cell migration
to the liver during infection, alternative chemoattractants that may
control CD4+ T cell migration include High Mobility Group Box-
1 (HMGB-1), a danger associated molecular pattern (DAMP) that
induces neutrophil accumulation in the liver during viral infection
[18], and which can act directly on T cells [19,20], and VAP-1,
which promotes T cell accumulation during ConA-induced liver
inflammation [21]. The role of IL-27 in inhibiting DAMP
pathways is yet to be examined in any model. Unexpectedly,
however, anti-IL-12p40 treatment only partially suppressed the
production of the chemotactic tissue-derived soluble signal(s) in
infected WSX-12/2 mice, despite preventing severe liver pathol-
ogy [14]. Thus, the tissue migratory signal is not simply produced
in the liver of infected WSX-12/2 mice due to severe tissue
damage. As well as directly targeting T cells, IL-27 may inhibit the
production of chemotaxins in the liver during malaria infection by
regulating the activation/function of macrophages/monocytes,
neutrophils and hepatocytes [1,2,22].
Surprisingly the numbers of intrahepatic mast cells, basophils,
neutrophils and resident monocytes/macrophages were unaltered
in infected WSX-12/2 mice and the numbers of inflammatory
monocytes were decreased in WSX-12/2 mice compared with
WT mice (Figure S2). Consequently, the increased migration of
CD4+ T cells to the liver of infected WSX-12/2 mice does not
appear to be driven by elevated intraheptic innate immune cell
responses. Furthermore, although purified hepatic CD4+ T cells
from infected (D14) WSX-12/2 and WT mice, promote the
migration of splenic CD4+ T cells from infected WSX-12/2 mice,
splenic CD4+ T cells do not display reduced migration towards
liver homegenates obtained from infected mice treated with anti-
CD4 mAbs (results not shown but provided for review). Thus, it
does not appear that intrahepatic CD4+ T cells significantly
contribute to production of the dominant tissue-chemotaxin(s) in
WSX-12/2 mice during infection.
Almost all the CD4+ T cells that migrated to, and accumulated
within, the livers of infected WSX-12/2 mice expressed T-bet and
KLRG-1, marking them as terminally differentiated Th1 cells.
The molecular pathways that govern the migratory capacity of
terminally differentiated Th1 cells in this model are unclear. Th1
cells migrate very efficiently towards CXCR3 and CCR5 ligands
[23,24] but our data suggest that they also migrate towards non-
classical, chemokine-independent signals emanating from inflamed
liver cells. Although we have not defined the receptor that may
control the migration of terminally differentiated Th1 cells in
infected WSX-12/2 mice, candidates include RAGE, the receptor
for HMGB-1, which is expressed at higher levels on Th1 cells [25],
and CD147, the cell membrane-expressed receptor for Cyclophi-
lin A [26]. RAGE promotes leukocyte recruitment in a mouse
model of peritonitis [27] and Cyclophilin A is released from
necrotic liver cells [28] and can direct activated CD4+ T cell
migration in vitro and in vivo [25,29].
In summary, we have examined the mechanisms through which
IL-27(R) signalling prevents pathological T cell accumulation in
the liver during malaria infection. We have shown that IL-27 does
not restrict CD4+ T cell proliferation or promote CD4+ T cell
apoptosis in situ within the liver. Rather our results strongly
different activation and subset markers. (E–F) The effect of anti-IL-12p40 mAb administration on the (E) frequencies and (F) total numbers of liver
accumulating CD4+ T cell subsets in WSX-12/2 mice. (G) The migration of splenic CD4+ T cells from anti-IL-12p40 mAb treated and untreated mice
towards liver homogenate cells from anti-IL-12p40 treated and untreated infected mice (D14 PI). Data are the mean +/2 SEM of the group with 3–
5 mice per group. Data are representative of 3 independent experiments. *P,0.05 WT vs. WSX-12/2 mice; #P,0.05 WSX-12/2 vs. WSX-12/2 + anti-IL-
12 treatment. ,P,0.05 WT vs. WSX-12/2 + anti-IL-12 treatment.
doi:10.1371/journal.pone.0078486.g004
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indicate that IL-27 suppresses T cell migration to non-lymphoid
tissues by limiting non-classical chemokine-independent pathways.
Our results provide new information on the role of IL-27 in
regulating T cell dependent immunopathology during inflamma-
tory disease. We are currently examining the hypothesis that IL-
27-regulated pathway(s) repress T cell accumulation in the liver by
non-directly helping restrict the release of DAMPs from damaged
hepatocytes and directly suppressing the expression of danger
receptors on surveillent T cells.
Supporting Information
Figure S1 Histopathology of hepatic inflammation and
tissue damage in malaria-infected WSX-12/2 mice. (A)
Representative pictures showing the nature and level of hepatic
pathology in malaria-infected WT and WSX-12/2 mice. (B)
Sections (D14) were examined by immunofluoescence following
staining with DAPI, anti-CD3 and anti-CD45 antibodies. Data are
representative of 2 independent experiments. Magnification 206.
(PDF)
Figure S2 Abrogation of WSX-1 signalling does not
globally affect innate cell accumulation within the liver
during malaria infection. The absolute numbers of (A) mast
cells: C-kit+IgE+FceR1+, (B) basophils: C-kit-FcEr1+, (C) inflam-
matory monocytes: CD11b+Ly6ChiLy6Glow/int (D) neutrophils:
CD11b+4-802Ly6GhiLy6Cint/low (E) CD11b2F4-80+Ly6-
C2Ly6G2 and (F) CD11b+F4-80+Ly6C2Ly6G2 cells in the liver
of naı¨ve and malaria infected (D14 PI) mice. (E, F) cells represent
resident monocytes and/or macrophages, including kupffer cells.
All cellular populations were first gated from CD3- cells. Data are
the mean +/2 SEM of the group with 3–4 mice per group. Data
are representative of 2 independent experiments. *P,0.05, WT
vs. WSX-12/2 mice.
(PDF)
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